With Virupaksha, you get a quality product with on-time delivery.
01 1Virupaksha Organics Limited
02 1Dr.Reddy's Laboratories Limited
03 1Neuland Laboratories Limited
04 1AURORE PHARMACEUTICALS PRIVATE LIMITED
05 1Aurobindo Pharma Limited
06 1Cadila Pharmaceuticals Limited
07 1Cipla Ltd.
08 1Dasami Lab Private Limited
09 2HETERO LABS LIMITED
10 1Hetero Labs Limited
11 2Jubilant Pharmova Limited
12 1Lundbeck Pharmaceuticals Italy S.p.A.
13 1MYLAN LABORATORIES LIMITED
14 1SHODHANA LABORATORIES PRIVATE LIMITED
15 1SMS Pharmaceuticals Limited
16 1Tianish Laboratories Private Limited
17 1Willow Birch Pharma, Inc
18 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 2ESCITALOPRAM OXALATE
02 15Escitalopram Oxalate
03 2Escitalopram oxalate
04 1escitalopram oxalate
01 1China
02 1Denmark
03 16India
04 2U.S.A
NDC Package Code : 51686-0011
Start Marketing Date : 2022-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-944
Start Marketing Date : 2012-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-0134
Start Marketing Date : 2017-11-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7565
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 45562-1130
Start Marketing Date : 2010-07-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 65372-1116
Start Marketing Date : 2006-05-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1143
Start Marketing Date : 2009-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-886
Start Marketing Date : 2017-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-177
Start Marketing Date : 2024-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-109
Start Marketing Date : 2011-02-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Escitalopram Oxalate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Escitalopram Oxalate, including repackagers and relabelers. The FDA regulates Escitalopram Oxalate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Escitalopram Oxalate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Escitalopram Oxalate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Escitalopram Oxalate supplier is an individual or a company that provides Escitalopram Oxalate active pharmaceutical ingredient (API) or Escitalopram Oxalate finished formulations upon request. The Escitalopram Oxalate suppliers may include Escitalopram Oxalate API manufacturers, exporters, distributors and traders.
click here to find a list of Escitalopram Oxalate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Escitalopram Oxalate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Escitalopram Oxalate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Escitalopram Oxalate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Escitalopram Oxalate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Escitalopram Oxalate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Escitalopram Oxalate suppliers with NDC on PharmaCompass.
We have 17 companies offering Escitalopram Oxalate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?